Towards a unified molecular mechanism for liganddependent activation of NR4A-RXR heterodimers
Related Experiment Video
Updated: May 16, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Xiaoyu Yu1,2, Yuanjun He3, Theodore M Kamenecka3
1Department of Biochemistry, Vanderbilt University, Nashville, Tennessee, United States.
Abstract:
A subset of nuclear receptors (NRs) function as permissive heterodimers with retinoid X receptor (RXR), defined by transcriptional activation in response to binding RXR agonist ligands. Permissive NR-RXR activation operates via a classical pharmacological mechanism, where binding of an RXR agonist increases coactivator recruitment to the heterodimer. However, we previously demonstrated that transcriptional activation of permissive Nurr1-RXRα (NR4A2-NR2B1) heterodimers by an RXR ligand set, which included pharmacological RXR agonists and selective Nurr1-RXRα agonists that function as antagonists of RXRα homodimers, occurs via a non-classical mechanism: ligand-binding domain (LBD) heterodimer dissociation (Yu et al., 2023). Here, we extend mechanistic ligand profiling of the same RXR ligand set to Nur77-RXRγ (NR4A1-NR2B3), which is evolutionarily related to Nurr1-RXRα. Biochemical and NMR protein-protein interaction profiling along with cellular transcription studies indicate that the RXR ligand set, which lacks selective Nur77-RXRγ agonists, may influence Nur77-RXRγ transcriptional activation through both classical pharmacological activation and LBD heterodimer dissociation. However, upon reanalyzing our previously published data for Nurr1-RXRα, we found that the inclusion of selective Nurr1-RXRα agonists was essential for elucidating the LBD heterodimer dissociation mechanism. Our findings underscore the need for a more functionally diverse RXR ligand set to explore Nur77-RXRγ activation and unify LBD heterodimer dissociation as a potential targeting mechanism for NR4A-RXR heterodimers in neurodegenerative and inflammatory diseases.
Insights
Nuclear receptors (NRs) form heterodimers with retinoid X receptor (RXR). This study reveals that activating Nur77-RXRγ heterodimers may involve both classical and non-classical mechanisms, highlighting the need for diverse RXR ligands.
Area of Science:
- Molecular Endocrinology
- Nuclear Receptor Signaling
- Biochemistry
Background:
- Nuclear receptors (NRs) form permissive heterodimers with retinoid X receptor (RXR), mediating transcriptional activation via RXR agonist binding.
- Classical activation involves increased coactivator recruitment upon RXR agonist binding.
- Previous work showed Nurr1-RXRα activation by specific ligands occurs through non-classical ligand-binding domain (LBD) heterodimer dissociation.
Purpose of the Study:
- To investigate the mechanism of Nur77-RXRγ heterodimer transcriptional activation using a defined RXR ligand set.
- To compare the activation mechanisms of Nur77-RXRγ with previously studied Nurr1-RXRα.
- To assess the role of LBD heterodimer dissociation in NR4A-RXRγ interactions.
Main Methods:
- Mechanistic ligand profiling of RXR ligands on Nur77-RXRγ.
- Biochemical and Nuclear Magnetic Resonance (NMR) protein-protein interaction assays.
- Cellular transcription assays to measure transcriptional activation.
Main Results:
- The tested RXR ligand set, lacking selective Nur77-RXRγ agonists, appears to influence Nur77-RXRγ activation through both classical and LBD heterodimer dissociation mechanisms.
- Re-analysis of Nurr1-RXRα data confirmed the necessity of selective agonists for identifying LBD heterodimer dissociation.
- Nur77-RXRγ activation mechanisms are potentially influenced by both classical and non-classical pathways.
Conclusions:
- A functionally diverse RXR ligand set is crucial for fully understanding Nur77-RXRγ activation.
- Ligand-induced LBD heterodimer dissociation is a potential therapeutic mechanism for NR4A-RXR heterodimers.
- Further research is needed to unify LBD heterodimer dissociation as a targeting strategy for neurodegenerative and inflammatory diseases.
More Related Videos
09:07Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
09:07Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Co-activators and Co-repressors
Signal Transduction: Overview
Typically, signal transduction involves three...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Internal Receptors
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...